NutriBand (NTRB) EBITDA Margin Growth (1y) (2019 - 2026)
NutriBand (NTRB) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
NutriBand |
41.91 Mn |
37.33 Mn |
88,941.00 |
61,057.00 |
| Date | Value |
|---|
| Jan 31, 2026 |
61,057.00 |
| Oct 31, 2025 |
-90,035.00 |
| Jul 31, 2025 |
-348.00 |
| Apr 30, 2025 |
25,072.00 |
| Jan 31, 2025 |
-61,633.00 |
| Oct 31, 2024 |
18,190.00 |
| Jul 31, 2024 |
-19,194.00 |
| Apr 30, 2024 |
-24,964.00 |
| Jan 31, 2024 |
6,932.00 |
| Oct 31, 2023 |
-22,881.00 |
| Jul 31, 2023 |
10,129.00 |
| Apr 30, 2023 |
-6,849.00 |
| Jan 31, 2023 |
48,774.00 |
| Oct 31, 2022 |
38,132.00 |
| Jul 31, 2022 |
1,555.00 |
| Apr 30, 2022 |
-7,169.00 |
| Jan 31, 2022 |
-15,906.00 |
| Oct 31, 2021 |
-54,448.00 |
| Jul 31, 2021 |
2,421.00 |
| Apr 30, 2021 |
27,265.00 |
